What is Dogwood Therapeutics's change in AP?

Dogwood Therapeutics (DWTX) reported change in AP of -$589.51K in Q1 2026.

How has Dogwood Therapeutics's change in AP changed year-over-year?

Dogwood Therapeutics's change in AP decreased by 348.4% year-over-year, from -$131.48K to -$589.51K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Dogwood Therapeutics DWTX Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

PfizerPFE

-$117.25M+54.2%

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

Collegium Pharmaceutical, Inc.COLL

-$3.83M-127%

BioventusBVS

-$15.37M+60.7%

Avanos MedicalAVNS

-$2.1M+67.2%

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's change in AP?: Dogwood Therapeutics (DWTX) reported change in AP of -$589.51K in Q1 2026.
How has Dogwood Therapeutics's change in AP changed year-over-year?: Dogwood Therapeutics's change in AP decreased by 348.4% year-over-year, from -$131.48K to -$589.51K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.